Engineering Biology for the Treatment of Solid Tumours : Enhancing T Cell Function and Longevity in the Tumour Microenvironment for Improved Cancer Immunotherapy
Engineering Biology for the Treatment of Solid Tumours : Enhancing T Cell Function and Longevity in the Tumour Microenvironment for Improved Cancer Immunotherapy
批准号:
10074648
负责人:
金额:
$6.3万
依托单位:
依托单位国家:
英国
项目类别:
Grant for R&D
财政年份:
2023
资助国家:
英国
项目状态:
已结题
起止时间:
2023 至 --
中文摘要
该项目旨在开发一种创新的癌症治疗方法,重点是在具有挑战性的实体肿瘤环境中提高免疫细胞(特别是T细胞)的功能和寿命。T细胞在我们身体对抗癌症的能力中起着至关重要的作用;然而,当面对实体肿瘤内部的恶劣条件时,它们往往会变得疲惫不堪,失去效力。我们提出的解决方案包括开发一种**尖端的遗传工具**,这种工具可以引入**T细胞**,使它们能够更好地承受恶劣的环境,并保持它们对抗癌症的能力。该工具将被设计为仅在特定条件下激活,确保它不会对T细胞的自然功能产生负面影响。通过开发这种突破性的方法,我们的目标是提高现有癌症免疫疗法的有效性,为实体瘤患者提供一种优越的治疗选择。这一创新为未来几年改善患者预后和改变癌症治疗带来了重大希望。这种新型癌症治疗方法的市场机会是巨大的,因为它解决了免疫肿瘤学领域未满足的需求。该解决方案的成功开发和实施不仅将使患者受益,而且还将支持英国和欧洲生态系统内新业务的增长。此外,这种创新的癌症疗法的社会经济影响将是巨大的,因为它有可能降低医疗成本,改善无数实体瘤患者的生活质量。总之,这个项目代表了对抗癌症的重大进步,并有可能使治疗前景变得更好。
英文摘要
This project aims to develop an innovative cancer treatment that focuses on **improving the function and longevity of immune cells**, specifically T cells, within the challenging environment of **solid tumours**. T cells play a crucial role in our body's ability to combat cancer; however, they often become exhausted and lose their effectiveness when facing the harsh conditions present within solid tumours.Our proposed solution involves the development of a **cutting-edge genetic tool** that can be introduced into **T cells**, allowing them to better withstand the difficult environment and maintain their ability to fight cancer. This tool will be designed to activate only under specific conditions, ensuring that it does not negatively impact the natural function of the T cells.By developing this groundbreaking approach, we aim to enhance the **effectiveness of existing cancer immunotherapies**, providing a superior treatment option for patients with solid tumours. This innovation holds significant promise for improving patient outcomes and transforming cancer treatment in the years to come.The **market opportunity** for this novel cancer treatment is vast, as it addresses an unmet need in the field of **immuno-oncology**. The successful development and implementation of this solution will not only benefit patients but also support the growth of new businesses within the UK and European ecosystems. Additionally, the **socio-economic impact** of this innovative cancer therapy will be substantial, as it has the potential to reduce healthcare costs and improve the quality of life for countless individuals affected by solid tumours. In summary, this project represents a significant advancement in the fight against cancer and holds the potential to transform the treatment landscape for the better.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Journal of Integrative Plant Biology
-
批准号:31024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:贺萍
-
依托单位: